{"studyId":"mel_iatlas_riaz_nivolumab_2017","cancerTypeId":"mel","name":"Melanoma (MSK, Cell 2017) - iAtlas Harmonized","description":"Whole-exome sequencing and neoantigen landscape analysis of tumors from 64 advanced melanoma patients, profiled before and after nivolumab treatment. The reprocessing of raw sequencing data is coordinated by <a href=\"https://cri-iatlas.org/\">CRI iAtlas</a>.","publicStudy":true,"pmid":"29033130","citation":"Riaz et al. Cell 2017","groups":"","status":1,"importDate":"2026-02-11 00:43:48","allSampleCount":107,"sequencedSampleCount":73,"cnaSampleCount":0,"mrnaRnaSeqSampleCount":107,"mrnaRnaSeqV2SampleCount":0,"mrnaMicroarraySampleCount":0,"miRnaSampleCount":0,"methylationHm27SampleCount":0,"rppaSampleCount":0,"massSpectrometrySampleCount":0,"completeSampleCount":0,"referenceGenome":"hg38","treatmentCount":0,"structuralVariantCount":0,"cancerType":{"id":"mel","name":"Melanoma","dedicatedColor":"Black","shortName":"MEL","parent":"skin"},"readPermission":true,"resourceCounts":[]}